Tag: Genomics

The term 'fusion drug' can refer to a variety of specialized treatments, each with a unique mechanism of action. What is fusion drug used for depends entirely on its specific therapeutic application, which can range from stopping viral infections to targeting the proteins that drive certain cancers.

In studies involving aged rats, exposure to nanomolar concentrations of the tetrapeptide Livagen significantly increased the rate of protein synthesis in liver cell cultures, almost matching the levels of young rat liver cells. This finding highlights its potential as a bioregulatory peptide, a class of short-chain amino acids investigated for their role in regulating various cellular processes.

Pioneered by Dr. Leroy Hood of the Institute for Systems Biology, P4 medicine represents a profound shift from reactive, symptom-based treatment to proactive, wellness-focused care. Understanding **what is P4 in medicine** reveals a model where strategies are not only tailored to individuals but also designed to predict and prevent disease before it occurs.